- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Is There a Role for FAPI PET in Urological Cancers? ; volume:28 ; number:6 ; day:24 ; month:8 ; year:2024 ; pages:721-725 ; date:11.2024
Molecular diagnosis & therapy ; 28, Heft 6 (24.8.2024), 721-725, 11.2024
- Urheber
-
Ortolan, Naima
Urso, Luca
Zamberlan, Ilaria
Filippi, Luca
Buffi, Nicolò Maria
Cittanti, Corrado
Uccelli, Licia
Bartolomei, Mirco
Evangelista, Laura
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40291-024-00735-9
- URN
-
urn:nbn:de:101:1-2501162106090.148294165595
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-15T07:35:27+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ortolan, Naima
- Urso, Luca
- Zamberlan, Ilaria
- Filippi, Luca
- Buffi, Nicolò Maria
- Cittanti, Corrado
- Uccelli, Licia
- Bartolomei, Mirco
- Evangelista, Laura
- SpringerLink (Online service)
Ähnliche Objekte (12)
FAPI-PET in cardiovascular disease
Comparative analysis of two timepoints on [18F]FAPI-42 PET/CT in various cancers
Melatonin and urological cancers: a new therapeutic approach
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
Prognostic factors in urological cancers : proceedings of the 1st International Symposium on Prognostic Factors in Urological Cancers, Munich, Germany 1992 ; 63 tables
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges
Correction to: Melatonin and urological cancers: a new therapeutic approach
Wnt signaling pathways in urological cancers: past decades and still growing
Supportive care interventions for men with urological cancers: a scoping review
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
The role of RNA modification in urological cancers: mechanisms and clinical potential
68Ga- or 18F-FAPI PET/CT—what it can and cannot
FAPI-PET in cardiovascular disease
Comparative analysis of two timepoints on [18F]FAPI-42 PET/CT in various cancers
Melatonin and urological cancers: a new therapeutic approach
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
Prognostic factors in urological cancers : proceedings of the 1st International Symposium on Prognostic Factors in Urological Cancers, Munich, Germany 1992 ; 63 tables
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges
Correction to: Melatonin and urological cancers: a new therapeutic approach
Wnt signaling pathways in urological cancers: past decades and still growing
Supportive care interventions for men with urological cancers: a scoping review
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
The role of RNA modification in urological cancers: mechanisms and clinical potential
68Ga- or 18F-FAPI PET/CT—what it can and cannot
FAPI-PET in cardiovascular disease
Comparative analysis of two timepoints on [18F]FAPI-42 PET/CT in various cancers
Melatonin and urological cancers: a new therapeutic approach
Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers
Prognostic factors in urological cancers : proceedings of the 1st International Symposium on Prognostic Factors in Urological Cancers, Munich, Germany 1992 ; 63 tables
Emerging photodynamic/sonodynamic therapies for urological cancers: progress and challenges
Correction to: Melatonin and urological cancers: a new therapeutic approach
Wnt signaling pathways in urological cancers: past decades and still growing
Supportive care interventions for men with urological cancers: a scoping review
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
The role of RNA modification in urological cancers: mechanisms and clinical potential